Pancreatic Cancer Research

ResearcherTokyo Medical UniversityActive in the last 2 years

Atsushi Sofuni

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5417-6752; OpenAlex author ID A5014477727. Sources: OpenAlex.

Their work

Papers
17 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
38
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 17

  1. Prognostic value of lactate dehydrogenase-to-albumin ratio in metastatic/recurrent pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel: a… First author DOI 10.21037/jgo-2026-0223↗
  2. Evaluating the Usefulness of the Blood Apolipoprotein A2 Isoform Index for Pancreatic Cancer Diagnosis. First author DOI 10.3390/cancers17071071↗
  3. Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. Co-author DOI 10.1007/s10147-023-02317-x↗
  4. A fatal case of massive hemobilia caused by invasive pancreatic cancer with median arcuate ligament syndrome: A case report. First author DOI 10.1097/md.0000000000035701↗
  5. High-intensity focused ultrasound therapy for pancreatic cancer. Co-author DOI 10.1007/s10396-022-01208-4↗
  6. Deep learning analysis for the detection of pancreatic cancer on endosonographic images: a pilot study. Co-author DOI 10.1002/jhbp.825↗
  7. Value of Low-Mechanical-Index Contrast-Enhanced Transabdominal Ultrasound for Diagnosis of Pancreatic Cancer: A Meta-analysis. Co-author DOI 10.1016/j.ultrasmedbio.2021.08.005↗
  8. Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HI… Co-author DOI 10.3390/curroncol28060409↗
  9. A Case of Unresectable Pancreatic Cancer with Long-Term Survival in High-Intensity Focused Ultrasound (HIFU) Therapy. Co-author DOI 10.1055/a-1061-7790↗
  10. Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement. Co-author DOI 10.1007/s11605-018-3722-0↗
  11. Elevated Polyamines in Saliva of Pancreatic Cancer. Co-author DOI 10.3390/cancers10020043↗
  12. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. Co-author DOI 10.3390/ijms18040767↗
  13. [The strategy of pancreatic cancer for early detection]. Co-author DOI 10.11405/nisshoshi.112.1484↗
  14. Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer. Co-author DOI 10.3748/wjg.v20.i28.9570↗
  15. Endoscopic double stenting for the treatment of malignant biliary and duodenal obstruction due to pancreatic cancer. Co-author DOI 10.1111/den.12063↗
  16. Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinic… Co-author DOI 10.1007/s00280-012-1822-1↗
  17. Prediction of a side effect and efficacy of adjuvant chemotherapy with gemcitabine for post operative patient of pancreatic cancer by a genetic polymorphism an… Last author DOI 10.5754/hge11729↗

Closest collaborators

The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takao Itoi · 15 shared papers, 2012–2026 · strength 1.66
  2. Shuntaro Mukai · 9 shared papers, 2014–2025 · strength 1.01
  3. Ryosuke Tonozuka · 10 shared papers, 2013–2025 · strength 0.91
  4. Yuichi Nagakawa · 7 shared papers, 2012–2026 · strength 0.87
  5. Reina Tanaka · 9 shared papers, 2014–2025 · strength 0.86
  6. Kenjiro Yamamoto · 7 shared papers, 2015–2025 · strength 0.85
  7. Yukitoshi Matsunami · 5 shared papers, 2018–2025 · strength 0.60
  8. Kazumasa Nagai · 4 shared papers, 2019–2025 · strength 0.54
  9. Yasutsugu Asai · 4 shared papers, 2018–2022 · strength 0.44
  10. Yoshiya Yamauchi · 1 shared paper, 2026 · strength 0.43
  11. Ryosuke Nakatsubo · 2 shared papers, 2021–2023 · strength 0.25
  12. Kento Shionoya · 1 shared paper, 2025 · strength 0.21
  13. Akihiko Tsuchida · 3 shared papers, 2012–2021 · strength 0.20
  14. Fuminori Moriyasu · 4 shared papers, 2013–2017 · strength 0.18
  15. ChristophF Dietrich · 1 shared paper, 2021 · strength 0.13
  16. Yasunobu Yamashita · 1 shared paper, 2021 · strength 0.13
  17. Reiko Ashida · 1 shared paper, 2021 · strength 0.13
  18. Naoyoshi Nagata · 1 shared paper, 2021 · strength 0.13
  19. Mirko D’Onofrio · 1 shared paper, 2021 · strength 0.13
  20. Masatoshi Kudo · 1 shared paper, 2021 · strength 0.13
  21. Masayuki Kitano · 1 shared paper, 2021 · strength 0.13
  22. Yoshiki Hirooka · 1 shared paper, 2021 · strength 0.13
  23. Makoto Sunamura · 2 shared papers, 2017–2018 · strength 0.11
  24. Shigeyuki Kawachi · 2 shared papers, 2017–2018 · strength 0.11
  25. Yuta Abe · 2 shared papers, 2012–2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.